Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d’Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network
Titel:
Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d’Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network
Auteur:
Hadoux, Julien Kanaan, Christina Durand, Alice Hescot, Ségolène Hautefeuille, Vincent Cadiot, Guillaume Tauveron, Igor Laboureau, Sandrine Do Cao, Christine Walter, Thomas Petorin, Caroline Blanchet, Odile Jannin, Arnaud Gu, Céline Faron, Matthieu Leteurtre, Emmanuelle Rousselet, Marie-Christine Zakeyh, Juliette J. Marchal, Aude Chatelain, Denis Beaulaton, Clément Hervieu, Valérie Ducreux, Michel Scoazec, Jean-Yves Baudin, Eric